In the present study, the capacity of DA and its precursor l-DOPA to block canonical, non-canonical, and α-syn-mediated modes of NLRP3 inflammasome activation in primary human microglia was examined and characterized, as this inhibition could have implications for the etiology of PD. Here, NLRP3 is linked to Parkinson disease.